Andrew Morrell

1.3k total citations
25 papers, 1.2k citations indexed

About

Andrew Morrell is a scholar working on Molecular Biology, Toxicology and Organic Chemistry. According to data from OpenAlex, Andrew Morrell has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 16 papers in Toxicology and 10 papers in Organic Chemistry. Recurrent topics in Andrew Morrell's work include Cancer therapeutics and mechanisms (23 papers), Bioactive Compounds and Antitumor Agents (16 papers) and Synthesis and bioactivity of alkaloids (10 papers). Andrew Morrell is often cited by papers focused on Cancer therapeutics and mechanisms (23 papers), Bioactive Compounds and Antitumor Agents (16 papers) and Synthesis and bioactivity of alkaloids (10 papers). Andrew Morrell collaborates with scholars based in United States and Poland. Andrew Morrell's co-authors include Mark Cushman, Yves Pommier, Smitha Antony, Glenda Kohlhagen, Keli Agama, Muthukaman Nagarajan, Thomas S. Dexheimer, Michael S. Placzek, Maris A. Cinelli and Martin Conda‐Sheridan and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Andrew Morrell

25 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Morrell United States	19	861	692	371	230	127	25	1.2k
Han‐Yue Qiu China	19	379 0.4×	625 0.9×	200 0.5×	125 0.5×	56 0.4×	52	967
Muthukaman Nagarajan United States	9	388 0.5×	333 0.5×	166 0.4×	111 0.5×	57 0.4×	15	599
Tsann‐Long Su Taiwan	15	449 0.5×	461 0.7×	68 0.2×	155 0.7×	39 0.3×	63	851
Rezk R. Ayyad Egypt	25	691 0.8×	1.1k 1.6×	119 0.3×	174 0.8×	22 0.2×	52	1.5k
Chii M. Lin United States	8	518 0.6×	875 1.3×	94 0.3×	190 0.8×	65 0.5×	8	1.2k
Yeh-Long Chen Taiwan	15	278 0.3×	308 0.4×	100 0.3×	80 0.3×	49 0.4×	23	568
Hany S. Ibrahim Egypt	23	785 0.9×	1.0k 1.5×	80 0.2×	153 0.7×	29 0.2×	46	1.3k
Tara Man Kadayat South Korea	20	476 0.6×	522 0.8×	201 0.5×	128 0.6×	12 0.1×	41	854
Rabah A.T. Serya Egypt	20	429 0.5×	671 1.0×	66 0.2×	178 0.8×	32 0.3×	38	1.0k
Magda A.‐A. El‐Sayed Egypt	18	501 0.6×	1.1k 1.7×	73 0.2×	138 0.6×	23 0.2×	40	1.4k

Countries citing papers authored by Andrew Morrell

Since Specialization

Citations

This map shows the geographic impact of Andrew Morrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Morrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Morrell more than expected).

Fields of papers citing papers by Andrew Morrell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Morrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Morrell. The network helps show where Andrew Morrell may publish in the future.

Co-authorship network of co-authors of Andrew Morrell

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Morrell. A scholar is included among the top collaborators of Andrew Morrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Morrell. Andrew Morrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cinelli, Maris A., et al.. (2018). Activity of Aromathecins against African Trypanosomes. Antimicrobial Agents and Chemotherapy. 62(11). 5 indexed citations

Morrell, Andrew, Martin Conda‐Sheridan, Christophe Marchand, et al.. (2012). Synthesis and Biological Evaluation of the First Dual Tyrosyl-DNA Phosphodiesterase I (Tdp1)–Topoisomerase I (Top1) Inhibitors. Journal of Medicinal Chemistry. 55(9). 4457–4478. 81 indexed citations

Chen, Lian, Martin Conda‐Sheridan, P. Venkat Reddy, et al.. (2012). Identification, Synthesis, and Biological Evaluation of the Metabolites of 3-Amino-6-(3′-aminopropyl)-5H-indeno[1,2-c]isoquinoline-5,11-(6H)dione (AM6–36), a Promising Rexinoid Lead Compound for the Development of Cancer Chemotherapeutic and Chemopreventive Agents. Journal of Medicinal Chemistry. 55(12). 5965–5981. 23 indexed citations

Conda‐Sheridan, Martin, P. Venkat Reddy, Andrew Morrell, et al.. (2012). Synthesis and Biological Evaluation of Indenoisoquinolines That Inhibit Both Tyrosyl-DNA Phosphodiesterase I (Tdp1) and Topoisomerase I (Top1). Journal of Medicinal Chemistry. 56(1). 182–200. 67 indexed citations

Park, Eun‐Jung, Tamara P. Kondratyuk, Andrew Morrell, et al.. (2011). Induction of Retinoid X Receptor Activity and Consequent Upregulation of p21WAF1/CIP1 by Indenoisoquinolines in MCF7 Cells. Cancer Prevention Research. 4(4). 592–607. 30 indexed citations

Cinelli, Maris A., Andrew Morrell, Thomas S. Dexheimer, et al.. (2011). Alcohol-, Diol-, and Carbohydrate-Substituted Indenoisoquinolines as Topoisomerase I Inhibitors: Investigating the Relationships Involving Stereochemistry, Hydrogen Bonding, and Biological Activity. Journal of Medicinal Chemistry. 54(14). 4937–4953. 38 indexed citations

Kiselev, Evgeny, Sean M. DeGuire, Andrew Morrell, et al.. (2011). 7-Azaindenoisoquinolines as Topoisomerase I Inhibitors and Potential Anticancer Agents. Journal of Medicinal Chemistry. 54(17). 6106–6116. 60 indexed citations

Cinelli, Maris A., Andrew Morrell, Thomas S. Dexheimer, et al.. (2010). The structure–activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode. Bioorganic & Medicinal Chemistry. 18(15). 5535–5552. 19 indexed citations

Pommier, Yves, Smitha Antony, Ze‐Hong Miao, et al.. (2007). Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance. Molecular Cancer Therapeutics. 6. 1 indexed citations

10.

Antony, Smitha, Keli Agama, Ze‐Hong Miao, et al.. (2007). Novel Indenoisoquinolines NSC 725776 and NSC 724998 Produce Persistent Topoisomerase I Cleavage Complexes and Overcome Multidrug Resistance. Cancer Research. 67(21). 10397–10405. 113 indexed citations

11.

Morrell, Andrew, Michael S. Placzek, Brian Grella, et al.. (2007). Optimization of the Indenone Ring of Indenoisoquinoline Topoisomerase I Inhibitors. Journal of Medicinal Chemistry. 50(18). 4388–4404. 93 indexed citations

12.

Morrell, Andrew, Michael S. Placzek, Jamin D. Steffen, et al.. (2007). Investigation of the Lactam Side Chain Length Necessary for Optimal Indenoisoquinoline Topoisomerase I Inhibition and Cytotoxicity in Human Cancer Cell Cultures. Journal of Medicinal Chemistry. 50(9). 2040–2048. 57 indexed citations

13.

Morrell, Andrew, Michael S. Placzek, Smitha Antony, et al.. (2007). Nitrated Indenoisoquinolines as Topoisomerase I Inhibitors: A Systematic Study and Optimization. Journal of Medicinal Chemistry. 50(18). 4419–4430. 62 indexed citations

14.

Antony, Smitha, Keli Agama, Ze‐Hong Miao, et al.. (2006). Bisindenoisoquinoline Bis-1,3-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylamino}propane bis(trifluoroacetate) (NSC 727357), a DNA Intercalator and Topoisomerase Inhibitor with Antitumor Activity. Molecular Pharmacology. 70(3). 1109–1120. 33 indexed citations

15.

Morrell, Andrew, Muthusamy Jayaraman, Muthukaman Nagarajan, et al.. (2006). Evaluation of indenoisoquinoline topoisomerase I inhibitors using a hollow fiber assay. Bioorganic & Medicinal Chemistry Letters. 16(16). 4395–4399. 15 indexed citations

16.

Nagarajan, Muthukaman, Andrew Morrell, Smitha Antony, et al.. (2006). Synthesis and Biological Evaluation of Bisindenoisoquinolines as Topoisomerase I Inhibitors. Journal of Medicinal Chemistry. 49(17). 5129–5140. 36 indexed citations

17.

Morrell, Andrew, Smitha Antony, Glenda Kohlhagen, Yves Pommier, & Mark Cushman. (2006). Synthesis of benz[d]indeno[1,2-b]pyran-5,11-diones: Versatile intermediates for the design and synthesis of topoisomerase I inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(7). 1846–1849. 44 indexed citations

18.

Morrell, Andrew, Smitha Antony, Glenda Kohlhagen, Yves Pommier, & Mark Cushman. (2006). A Systematic Study of Nitrated Indenoisoquinolines Reveals a Potent Topoisomerase I Inhibitor. Journal of Medicinal Chemistry. 49(26). 7740–7753. 62 indexed citations

19.

Nagarajan, Muthukaman, Andrew Morrell, Smitha Antony, et al.. (2004). Synthesis and Anticancer Activity of Simplified Indenoisoquinoline Topoisomerase I Inhibitors Lacking Substituents on the Aromatic Rings. Journal of Medicinal Chemistry. 47(23). 5651–5661. 121 indexed citations

20.

Morrell, Andrew, Smitha Antony, Glenda Kohlhagen, Yves Pommier, & Mark Cushman. (2004). Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(14). 3659–3663. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact